• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白D1在人垂体肿瘤中的差异表达:与MIB-1和p27/Kip1标记指数的关系。

Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.

作者信息

Hewedi Iman H, Osman Wesam M, El Mahdy Manal M

机构信息

Department of Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.

出版信息

J Egypt Natl Canc Inst. 2011 Dec;23(4):171-9. doi: 10.1016/j.jnci.2011.11.003. Epub 2011 Dec 29.

DOI:10.1016/j.jnci.2011.11.003
PMID:22776845
Abstract

BACKGROUND

Pituitary tumors are a common form of endocrine neoplasia. However few studies assessed the expression of the principal cyclin regulating checkpoint exit, cyclin D1. Cyclin D1 expression in pituitary tumors and its possible relation to MIB-1 and p27/Kip1 labeling indices (LIs) was explored.

DESIGN

We studied a total of 199 pituitaries, including normal pituitaries (n=7), pituitary adenomas (n=187), and pituitary carcinoma (n=5). All tissues were tested as cores of archived tissue microarrays that were immunostained for cyclin D1, MIB-1 and p27 using a standard technique. Tissue cores were subjected to automated analysis to evaluate the staining LIs.

RESULTS

No cyclin D1 positive cells in the normal anterior pituitary gland was found. Sparse nuclear staining was noted in pituitary tumors. Higher expression of cyclin D1 was noted in pituitary carcinomas compared to adenomas (p<0.001), in non-functioning adenomas compared to functioning ones (p<0.001) in macroadenomas versus microadenomas (p=0.017) and in recurrent non recurrent adenomas (p<0.001). Cyclin D1 LI and MIB-1 LI were related among adenomas (p<0.001) and carcinomas (p=0.041). p27 LI was neither related to pituitary adenoma recurrence nor invasion.

CONCLUSIONS

Expression of cyclin D1 in pituitary tumors is related to cell proliferation, recurrence, and metastatic potential. Nuclear cyclin D1 expression is a good marker of aggressive behavior in pituitary tumors.

摘要

背景

垂体肿瘤是内分泌肿瘤的常见形式。然而,很少有研究评估调节检查点退出的主要细胞周期蛋白细胞周期蛋白D1的表达。本研究探讨了垂体肿瘤中细胞周期蛋白D1的表达及其与MIB-1和p27/Kip1标记指数(LIs)的可能关系。

设计

我们共研究了199个垂体,包括正常垂体(n = 7)、垂体腺瘤(n = 187)和垂体癌(n = 5)。所有组织均作为存档组织微阵列的芯进行检测,采用标准技术对细胞周期蛋白D1、MIB-1和p27进行免疫染色。对组织芯进行自动分析以评估染色LIs。

结果

在正常垂体前叶未发现细胞周期蛋白D1阳性细胞。在垂体肿瘤中观察到稀疏的核染色。与腺瘤相比,垂体癌中细胞周期蛋白D1的表达更高(p < 0.001),与功能性腺瘤相比,无功能性腺瘤中细胞周期蛋白D1的表达更高(p < 0.001),大腺瘤与微腺瘤相比(p = 0.017),复发性与非复发性腺瘤相比(p < 0.001)。腺瘤(p < 0.001)和癌(p = 0.041)中细胞周期蛋白D1 LI和MIB-1 LI相关。p27 LI与垂体腺瘤的复发和侵袭均无关。

结论

垂体肿瘤中细胞周期蛋白D1的表达与细胞增殖、复发和转移潜能有关。细胞核细胞周期蛋白D1的表达是垂体肿瘤侵袭性的良好标志物。

相似文献

1
Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27/Kip1 labeling indices.细胞周期蛋白D1在人垂体肿瘤中的差异表达:与MIB-1和p27/Kip1标记指数的关系。
J Egypt Natl Canc Inst. 2011 Dec;23(4):171-9. doi: 10.1016/j.jnci.2011.11.003. Epub 2011 Dec 29.
2
Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors.细胞周期抑制剂p27Kip1在正常促肾上腺皮质激素细胞、促肾上腺皮质激素肿瘤及恶性垂体肿瘤中低表达。
J Clin Endocrinol Metab. 1999 Oct;84(10):3823-30. doi: 10.1210/jcem.84.10.6066.
3
Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.细胞周期调控因子免疫组化染色结果:预测功能性垂体腺瘤的复发。
World Neurosurg. 2014 Mar-Apr;81(3-4):563-75. doi: 10.1016/j.wneu.2013.09.035. Epub 2013 Sep 22.
4
Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.磷酸化p27(Kip1)蛋白和Jun激活域结合蛋白1在人垂体肿瘤中的表达
J Clin Endocrinol Metab. 2002 Jun;87(6):2635-43. doi: 10.1210/jcem.87.6.8517.
5
Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries.转化生长因子-β、转化生长因子-β受体II以及p27Kip1在人非肿瘤性和肿瘤性垂体中的表达
Am J Pathol. 1997 Aug;151(2):509-19.
6
Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.垂体腺瘤和正常垂体组织中细胞周期蛋白的表达分析。
Clin Endocrinol (Oxf). 2000 Sep;53(3):337-44. doi: 10.1046/j.1365-2265.2000.01088.x.
7
Cyclin D and cyclin E expression in normal and adenomatous pituitary.细胞周期蛋白D和细胞周期蛋白E在正常及腺瘤性垂体中的表达
Eur J Endocrinol. 2000 Jul;143(1):R1-6. doi: 10.1530/eje.0.143r001.
8
Pathobiology of pituitary adenomas and carcinomas.垂体腺瘤与癌的病理生物学
Neurosurgery. 2006 Aug;59(2):341-53; discussion 341-53. doi: 10.1227/01.NEU.0000223437.51435.6E.
9
Differential expression of galectin-3 in pituitary tumors.半乳糖凝集素-3在垂体肿瘤中的差异表达。
Cancer Res. 2003 May 1;63(9):2251-5.
10
Immunohistochemical analysis of p27 (Kip1) in human pituitary glands and in various types of pituitary adenomas.人垂体及各类垂体腺瘤中p27(Kip1)的免疫组织化学分析。
Endocr Pathol. 2001 Summer;12(2):181-8. doi: 10.1385/ep:12:2:181.

引用本文的文献

1
The Roles of PD-L1, Ki-67, P53, and Cyclin D1 in PitNETs: Diagnostic and Prognostic Implications in a Series of 74 Patients.PD-L1、Ki-67、P53和细胞周期蛋白D1在垂体神经内分泌肿瘤中的作用:74例患者的诊断和预后意义
Int J Mol Sci. 2025 Aug 13;26(16):7830. doi: 10.3390/ijms26167830.
2
The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.无功能促肾上腺皮质激素瘤的临床病理特征及预后:一项更新的系统评价和荟萃分析
Endocrine. 2023 Dec;82(3):527-535. doi: 10.1007/s12020-023-03449-w. Epub 2023 Jul 18.
3
Prognostic Factors for Invasiveness and Recurrence of Pituitary Adenomas: A Series of 94 Patients.
垂体腺瘤侵袭性和复发的预后因素:94例患者系列研究
Diagnostics (Basel). 2022 Oct 5;12(10):2413. doi: 10.3390/diagnostics12102413.
4
Recurrence Rate and Exploration of Clinical Factors after Pituitary Adenoma Surgery: A Systematic Review and Meta-Analysis based on Computer Artificial Intelligence System.基于计算机人工智能系统的垂体腺瘤手术后复发率及临床因素分析的系统评价和荟萃分析。
Comput Intell Neurosci. 2022 Oct 14;2022:6002672. doi: 10.1155/2022/6002672. eCollection 2022.
5
Overexpression of microRNA-34a Attenuates Proliferation and Induces Apoptosis in Pituitary Adenoma Cells via SOX7.微小RNA-34a的过表达通过SOX7减弱垂体腺瘤细胞的增殖并诱导其凋亡。
Mol Ther Oncolytics. 2018 Jul 9;10:40-47. doi: 10.1016/j.omto.2018.07.001. eCollection 2018 Sep 28.
6
Advancements in the study of miRNA regulation during the cell cycle in human pituitary adenomas.在人类垂体腺瘤细胞周期中 miRNA 调控研究的进展。
J Neurooncol. 2017 Sep;134(2):253-258. doi: 10.1007/s11060-017-2518-5. Epub 2017 Jun 2.
7
Transcriptome Analysis Showed a Differential Signature between Invasive and Non-invasive Corticotrophinomas.转录组分析显示侵袭性和非侵袭性促肾上腺皮质激素瘤之间存在差异特征。
Front Endocrinol (Lausanne). 2017 Mar 22;8:55. doi: 10.3389/fendo.2017.00055. eCollection 2017.
8
Genetic aspects of pituitary carcinoma: A systematic review.垂体癌的遗传学方面:一项系统综述。
Medicine (Baltimore). 2016 Nov;95(47):e5268. doi: 10.1097/MD.0000000000005268.
9
Cold inducible RNA binding protein upregulation in pituitary corticotroph adenoma induces corticotroph cell proliferation via Erk signaling pathway.垂体促肾上腺皮质激素腺瘤中冷诱导RNA结合蛋白上调通过Erk信号通路诱导促肾上腺皮质激素细胞增殖。
Oncotarget. 2016 Feb 23;7(8):9175-87. doi: 10.18632/oncotarget.7037.